Company Valuation: Bionime Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 4,057 4,566 4,685 4,549 3,949 4,003
Change - 12.53% 2.61% -2.9% -13.19% 1.37%
Enterprise Value (EV) 1 5,664 6,284 6,677 6,917 6,733 6,577
Change - 10.94% 6.25% 3.59% -2.65% -2.32%
P/E 65.9x 52.6x 52.2x 748x -31x -22.2x
PBR 1.96x 2.21x 2.26x 2.29x 2.1x 2.29x
PEG - 1.3x 18.78x -8x 0x -0.5x
Capitalization / Revenue 2.43x 2.47x 2.12x 2.59x 2.04x 2.18x
EV / Revenue 3.39x 3.4x 3.02x 3.94x 3.48x 3.58x
EV / EBITDA 33.6x 29.4x 25x 54x 10,327x -157x
EV / EBIT 268x 83.5x 50.8x -519x -43.4x -33.3x
EV / FCF -84.5x -119x -34.4x -26.3x -25.7x 28.9x
FCF Yield -1.18% -0.84% -2.91% -3.81% -3.9% 3.46%
Dividend per Share 2 1.875 1.818 1.909 1.818 - -
Rate of return 3.04% 2.64% 2.72% 2.67% - -
EPS 2 0.9365 1.309 1.346 0.0909 -1.9 -2.683
Distribution rate 200% 139% 142% 2,000% - -
Net sales 1 1,669 1,850 2,211 1,756 1,934 1,839
EBITDA 1 168.4 213.8 267.5 128.1 0.652 -41.96
EBIT 1 21.12 75.29 131.4 -13.34 -155.2 -197.4
Net income 1 62.43 87.41 91.02 6.209 -127.2 -180.3
Net Debt 1 1,607 1,718 1,992 2,367 2,784 2,574
Reference price 2 61.73 68.92 70.19 68.01 58.83 59.50
Nbr of stocks (in thousands) 65,723 66,251 66,748 66,894 67,135 67,285
Announcement Date 3/24/21 3/30/22 3/15/23 3/15/24 3/31/25 3/31/26
1TWD in Million2TWD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 140M
-56.18x16.84x-123.24x-.--% 21.61B
17.26x1.96x8.16x1.49% 9.69B
23.57x4.46x12.55x - 6.79B
-56.18x8.67x-72.79x-.--% 5.81B
18.87x6.47x14.62x3.05% 5.1B
177.67x4.47x29.29x-.--% 4.94B
20.23x3.55x11.05x1.88% 4.21B
16.29x - - 3.93% 2.74B
Average 20.19x 6.63x -17.19x 1.48% 6.78B
Weighted average by Cap. -1.80x 9.17x -45.68x 0.9%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 4737 Stock
  4. Valuation Bionime Corporation